ArticleInternational journal of cardiology. Congenital heart disease2022
Ten years of pediatric congenital heart disease surgery in a Caribbean nation.
Article in International journal of cardiology. Congenital heart disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Sex differences in global burden of Congenital Heart Anomalies in children under five from 1990 to 2021.PloS one · 2026Article
- Editor's corner & issue at a glance.International journal of cardiology. Congenital heart disease · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Socioeconomical limitations in developing countries make congenital heart disease surgery (CHDs) a challenge that often relays on humanitarian efforts. We aimed to describe the evolution of an established pediatric CHDs program in the Dominican Republic and the impact of international medical missions (IMM) on its sustainability. Methods: Data of cases operated from 2009 to 2018 were analyzed using Pearson's chi-squared test to study trends between a 5-year implementation period (T1) January 2009-December 2013, and subsequent consolidation (T2) January 2014-December 2018. Results: 1344 consecutive patients were intervened: T1 = 278 (21%), age 7 ± 5 years, F 51%, mean 56 cases/year; T2 = 1066 (79%), age 5 ± 4 years, F 49%, mean 213 cases/year (p < 0.001 T1 vs. T2); T1 RACHS>2 interventions occurred at a mean of 11/year, and 27/year during T2 (p < 0.05); there was an increase in operated children <1 year of age [T1 = 32 (12%) vs. T2 = 299 (28%) p = 0.0001]. During T1, IMM cases accounted for 198 (71%) and 92 (9%) during T2 (p < 0.001). Yearly mortality varied in parallel to case complexity, however no difference in cumulative mortality was observed T1 vs. T2 (figure). Conclusions: In this CHDs program, there was robust growth without negatively impacting outcomes while IMM participation dropped. Integration of local and regional networks may facilitate reproducing these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.